OnabotulinumtoxinA for adductor spasmodic dysphonia (ADSD): Functional results and the role of dosage
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patientsThe Laryngoscope, 2015
- Patient perceptions of factors leading to spasmodic dysphonia: A combined clinical experience of 350 patientsThe Laryngoscope, 2011
- Spasmodic dysphonia and botulinum toxin: experience from the largest treatment seriesEuropean Journal of Neurology, 2010
- Mode of Action of Botulinum Neurotoxins: Current Vaccination Strategies and Molecular Immune RecognitionCritical Reviews in Immunology, 2010
- Dosage changes in patients with long‐term botulinum toxin use for laryngeal dystoniaOtolaryngology–Head and Neck Surgery, 2009
- Vocal aging and adductor spasmodic dysphonia: Response to botulinum toxin injectionClinical Interventions in Aging, 2008
- Impact on Quality of Life of Botulinum Toxin Treatments for Spasmodic Dysphonia and Oromandibular DystoniaJAMA Otolaryngology–Head & Neck Surgery, 2001
- Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patientsThe Laryngoscope, 1998
- Female predominance in spasmodic dysphoniaJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Spastic dysphonia: A continuum disorderJournal of Communication Disorders, 1981